Cite
Efficacy of natural killer cell activity as a biomarker for predicting immunotherapy response in non‐small cell lung cancer
MLA
Myeong Geun Choi, et al. “Efficacy of Natural Killer Cell Activity as a Biomarker for Predicting Immunotherapy Response in Non‐small Cell Lung Cancer.” Thoracic Cancer, vol. 11, no. 11, Nov. 2020, pp. 3337–45. EBSCOhost, https://doi.org/10.1111/1759-7714.13677.
APA
Myeong Geun Choi, Yeon Joo Kim, Jae Cheol Lee, Jin Kyung Rho, & Chang‐Min Choi. (2020). Efficacy of natural killer cell activity as a biomarker for predicting immunotherapy response in non‐small cell lung cancer. Thoracic Cancer, 11(11), 3337–3345. https://doi.org/10.1111/1759-7714.13677
Chicago
Myeong Geun Choi, Yeon Joo Kim, Jae Cheol Lee, Jin Kyung Rho, and Chang‐Min Choi. 2020. “Efficacy of Natural Killer Cell Activity as a Biomarker for Predicting Immunotherapy Response in Non‐small Cell Lung Cancer.” Thoracic Cancer 11 (11): 3337–45. doi:10.1111/1759-7714.13677.